2nd Annual Life Sciences AI Summit
February 20 – 21, 2025 | New York City Bar Association, New York, NY
AI is a transformative force that is revolutionizing efficiencies while necessitating comprehensive strategies to address legal, regulatory, ethical and compliance challenges. ACI's 2nd Annual Life Sciences AI Summit is the legal, regulatory, and compliance event for safe and responsible innovation in the biopharma and medical device/diagnostic industries.
This year's co-chairs include Lora Spencer (Principal Global Litigation & Investigations Counsel, Medtronic) and Nick Mercker (AVP, Assistant General Counsel - Chief Privacy Officer and Head of Privacy, Cyber and AI Legal, Eli Lilly and Company).
This year's hot topics and sessions include:
Shaping the Future of the Life Sciences: The EU AI Act’s Impact
Navigating FDA and EMA Directives for AI in Life Sciences
AI Litigation Across the Lifecycle of Life Sciences Products: From Pre-Commercialization to Post-Market Risks
AI Governance and Regulatory Sandboxes: Testing Innovation in Life Sciences
The Future of AI in the Life Sciences: Post-Election Regulatory Shifts and Strategic
This conference is essential for anyone working in the life sciences industry involved in the development, deployment, or use of AI-based technologies. The knowledge and insights gained at this summit will enable the successful navigation of the complex legal and regulatory landscape complicating AI in life sciences.
Attend the 2nd Annual Life Sciences AI Summit on February 20 – 21, 2025, at the New York City Bar Association in New York, NY. Visit https://bit.ly/3Yq1U1s to learn more.
Save 10% with the ChemLinked promo code: D10-999-CHEMLINKED25